Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,122 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Epstein-barr virus-associated smooth muscle tumors after bone marrow transplantation.
Hayase E, Fujimoto K, Mitsuhashi T, Hatanaka Y, Yoshida M, Takemura R, Iwasaki J, Shiratori S, Sugita J, Kondo T, Tanaka J, Imamura M, Matsuno Y, Teshima T. Hayase E, et al. Among authors: teshima t. Transplantation. 2014 Jan 15;97(1):e1-3. doi: 10.1097/01.TP.0000437912.60638.23. Transplantation. 2014. PMID: 24374766 No abstract available.
Reduced-intensity unrelated donor bone marrow transplantation for hematologic malignancies.
Kim SW, Matsuo K, Fukuda T, Hara M, Matsue K, Taniguchi S, Eto T, Tanimoto M, Wake A, Hatanaka K, Nakao S, Ishida Y, Harada M, Utsunomiya A, Imamura M, Kanda Y, Sunami K, Kawano F, Takaue Y, Teshima T. Kim SW, et al. Among authors: teshima t. Int J Hematol. 2008 Oct;88(3):324-330. doi: 10.1007/s12185-008-0163-7. Epub 2008 Sep 17. Int J Hematol. 2008. PMID: 18797985
Diagnosis and evaluation of intestinal graft-versus-host disease after allogeneic hematopoietic stem cell transplantation following reduced-intensity and myeloablative conditioning regimens.
Yamasaki S, Miyagi-Maeshima A, Kakugawa Y, Matsuno Y, Ohara-Waki F, Fuji S, Morita-Hoshi Y, Mori M, Kim SW, Mori S, Fukuda T, Tanosaki R, Shimoda T, Tobinai K, Saito D, Takaue Y, Teshima T, Heike Y. Yamasaki S, et al. Among authors: teshima t. Int J Hematol. 2013 Mar;97(3):421-6. doi: 10.1007/s12185-013-1297-9. Epub 2013 Feb 23. Int J Hematol. 2013. PMID: 23435651 Clinical Trial.
[Upfront of prophylaxis and treatment of GVHD].
Sugita J, Teshima T. Sugita J, et al. Among authors: teshima t. Rinsho Ketsueki. 2013 Feb;54(2):156-66. Rinsho Ketsueki. 2013. PMID: 23470822 Review. Japanese. No abstract available.
Unrelated allogeneic bone marrow-derived mesenchymal stem cells for steroid-refractory acute graft-versus-host disease: a phase I/II study.
Muroi K, Miyamura K, Ohashi K, Murata M, Eto T, Kobayashi N, Taniguchi S, Imamura M, Ando K, Kato S, Mori T, Teshima T, Mori M, Ozawa K. Muroi K, et al. Among authors: teshima t. Int J Hematol. 2013 Aug;98(2):206-13. doi: 10.1007/s12185-013-1399-4. Epub 2013 Jul 17. Int J Hematol. 2013. PMID: 23860964 Clinical Trial.
Successful engraftment in HLA-mismatched bone marrow transplantation despite the persistence of high-level donor-specific anti-HLA-DR antibody.
Shiratori S, Ito M, Yoneoka M, Hayasaka K, Hayase E, Iwasaki J, Sugita J, Shigematsu A, Fujimoto K, Kondo T, Shimizu C, Teshima T. Shiratori S, et al. Among authors: teshima t. Transplantation. 2013 Sep 15;96(5):e34-44. doi: 10.1097/TP.0b013e31829f7595. Transplantation. 2013. PMID: 23995866 No abstract available.
Bone marrow graft-versus-host disease: evaluation of its clinical impact on disrupted hematopoiesis after allogeneic hematopoietic stem cell transplantation.
Shono Y, Shiratori S, Kosugi-Kanaya M, Ueha S, Sugita J, Shigematsu A, Kondo T, Hashimoto D, Fujimoto K, Endo T, Nishio M, Hashino S, Matsuno Y, Matsushima K, Tanaka J, Imamura M, Teshima T. Shono Y, et al. Among authors: teshima t. Biol Blood Marrow Transplant. 2014 Apr;20(4):495-500. doi: 10.1016/j.bbmt.2013.12.568. Epub 2013 Dec 27. Biol Blood Marrow Transplant. 2014. PMID: 24374213 Free article.
High level of serum soluble interleukin-2 receptor at transplantation predicts poor outcome of allogeneic stem cell transplantation for adult T cell leukemia.
Shigematsu A, Kobayashi N, Yasui H, Shindo M, Kakinoki Y, Koda K, Iyama S, Kuroda H, Tsutsumi Y, Imamura M, Teshima T. Shigematsu A, et al. Among authors: teshima t. Biol Blood Marrow Transplant. 2014 Jun;20(6):801-5. doi: 10.1016/j.bbmt.2014.02.014. Epub 2014 Feb 22. Biol Blood Marrow Transplant. 2014. PMID: 24565990 Free article.
[Control of graft-versus-host disease].
Sugita J, Teshima T. Sugita J, et al. Among authors: teshima t. Rinsho Ketsueki. 2014 Feb;55(2):170-6. Rinsho Ketsueki. 2014. PMID: 24598183 Review. Japanese. No abstract available.
1,122 results